Cirkulin Artichoke Tablets
Natural health product licensed in Canada
- Licence holder
- Roha Arzneitmittel GmbH
- NPN or DIN-HM
- 80004756
- Status
- Active licence
- Licence date
- 17 December 2007
- Revision date
- Not provided
- Form
- Comprimé
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
gomme acacia, Lactose, Hydroxypropylméthylcellulose, Dioxyde de silicium, Dioxyde de titane, Maltodextrine, Saccharose, glucose syrup, Talc, Stéarate de magnésium, Carbonate de calcium, Eau purifiée, Cellulose - microcrystalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | Not specified | 3 Tous les jours |
| Adultes | Not specified | 1 Comprimé | 3 Tous les jours |
Uses authorised in Canada
Cirkulin Artichoke Tablets facilitate digestion and relieve the symptoms associated with dyspepsia. They are a natural source of antioxidants for the maintenance of good health. Cirkulin Artichoke Tablets help to maintain healthy cholesterol levels.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80004756
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.